Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Phase 3]
Phase 3 trial comparing Berodual Respimat with the Berodual MA Inhaler in patients with asthma, chronic obstructive pulmonary disease, or mi…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED) [Phase 2, Phase 3]
Completed Phase 2/3 trial evaluating the efficacy and long-term safety of a ragweed pollen sublingual tablet in adults with ragweed-induced …
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Determining the Optimal Adenosine Provocation Test [NA]
A completed clinical trial evaluating how to determine the optimal adenosine provocation test for asthma.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: Safety and Efficacy of YHD001 in Asthma [Phase 2]
Phase 2 study assessing safety and efficacy of YHD001 in asthma has been completed.
-
CLINICAL_TRIALS trial_result · 2014-07-10Clinical Trial Update: A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities [Phase 3]
Phase 3 clinical trial update evaluating a collaborative care model to improve blood pressure control and reduce racial disparities in treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Phase 4]
A Phase 4 trial comparing Combivent to salbutamol in asthma patients with methacholine-induced bronchospasm has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Special Drug Use Investigation for ADOAIR Metered-dose Inhaler (Pediatric)
A clinical trial update indicates completion of a pediatric special drug use investigation for the ADOAIR metered-dose inhaler for asthma.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis [Phase 3]
Phase 3 trial evaluating Combivent Aerosol and Spacer for adults with moderate to severe asthma crisis was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Exhaled Levels of Nitric Oxide [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated exhaled nitric oxide levels in participants with tetraplegia and asthma; results have been posted follo…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma [Phase 3]
Phase 3 trial evaluating tiotropium delivered by Respimat inhaler (2.5 and 5 mcg once daily) versus placebo in adults with moderate to sever…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234) [Phase 2, Phase 3]
Clinical trial update reporting efficacy and long-term safety of a ragweed sublingual immunotherapy tablet (SCH 39641) in adults with ragwee…
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: The Development of a Clinical Test to Assess the Inflammatory Phenotype of Asthma
This document reports on the completion of a clinical trial focused on developing a diagnostic test to assess the inflammatory phenotype of …
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma [Phase 2]
Phase 2 trial evaluating the bronchoprotective efficacy and safety of orally inhaled BI 1744 CL in patients with intermittent asthma; result…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts [Phase 1]
Phase 1 safety study update of sublingual immunotherapy tablets containing house dust mite allergen extracts; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases [Phase 4]
Phase 4 clinical trial evaluating aspirin desensitization for aspirin-exacerbated respiratory disease has completed, assessing its effect on…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: AZISAST Study: AZIthromycin in Severe ASThma Study [Phase 4]
Phase 4 trial evaluating AZIthromycin in severe asthma completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients. [Phase 2]
A Phase 2 study of JNJ-18054478 in asthma patients was terminated; the update notes the trial’s status and available safety/efficacy data.
-
CLINICAL_TRIALS trial_result · 2014-06-11Clinical Trial Update: Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma [Phase 2]
Phase 2 study evaluating 4 weeks of inhaled BI 1744 CL in asthma patients reported efficacy and safety outcomes.
-
CLINICAL_TRIALS trial_result · 2014-06-09Clinical Trial Update: Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma [Phase 2]
Phase 2 study evaluating esomeprazole magnesium (Nexium) for potential anti-asthmatic effects in asthma with GERD. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma. [Phase 3]
Phase 3 trial update comparing FF/VI combinations (200/25 mcg and 100/25 mcg) with FF alone (100 mcg) in adults and adolescents with persist…
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma. [Phase 2]
A Phase 2 study assessed four doses of BI 1744 CL delivered via the Respimat inhaler in patients with asthma; the trial has completed and re…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of MEDI-528 in Adults [Phase 2]
Phase 2 trial evaluating MEDI-528 for asthma in adults has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD. [Phase 2]
This Phase 2 trial evaluates 4 weeks of inhaled BI 1744 CL in patients with chronic obstructive pulmonary disease, reporting on efficacy and…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma [Phase 3]
A Phase 3 trial evaluated on-demand budesonide/formoterol versus regular budesonide/formoterol plus PRN terbutaline in mild-to-moderate asth…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Biomarkers of Cockroach Sublingual Immunotherapy 2 [Phase 1, Phase 2]
Phase 1/Phase 2 trial update reporting biomarker findings from cockroach sublingual immunotherapy in asthma and perennial allergic rhinitis,…